An ultrasensitive FRET-based fluorescent low molecular weight heparin nanoprobe for quantifying heparanase activity

Yayun Gu,Lizhong Peng,Weihua Ding,Yang Wang,Xuhui Zeng

DOI: https://doi.org/10.1016/j.talanta.2022.124207

IF: 6.1

2022-12-22

Talanta

Abstract:Heparanase (HPA) is a multifaceted endo -β-glucuronidase, and its dysregulation facilitates cancer metastasis. Developing techniques for fast and sensitively monitoring HPA enzymatic activity is crucial for searching for molecular therapies targeting HPA. Herein, we developed a novel fluorescence resonance energy transfer (FRET)-based nanoprobe AuNCs-LMWH-AuNRs, with and AuNRs/end-NH 2 /side-SiO 2 attached to the non-reducing terminus and reducing terminus of low molecular weight heparin (LMWH), respectively. exhibited an absolute quantum yield of 1.1%. The absorption spectra of AuNRs/end-NH 2 /side-SiO 2 (825 nm for maximum longitudinal absorption) and the emission spectra of (824 nm for maximum emission) were precisely overlapping, further enhancing the efficiency of FRET. In the presence of HPA, the LMWH nanoprobe exhibited an ultrasensitive response with excitation/emission wavelength (lambda (ex) = 560 nm, lambda (em) = 824 nm). The probe presented a wide linear dynamic detection range (LDR) of 0.125 ng/μL - 0.01 μg/μL in vitro with a limit of detection (LODs) of 82.15 pM (0.43 pg/μL). The excellent selectivity and good fluorescence turn-on efficiency of the probe made it possible for one-step detection of cellular heparanase activity. High throughput screening of HPA inhibitors also can be accomplished using the highly efficient LMWH nanoprobe.

chemistry, analytical